Almac Receives Appreciation Award from Otsuka America Pharmaceutical, Inc.
July 31, 2013
In June 2013, Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, hosted Otsuka America Pharmaceutical Inc.’s (OAPI) Clinical Trial Supply team at Almac’s North American Headquarters in Souderton, PA. The highlight of the meeting was a presentation of an award to the Almac team by Brent Kelly, OAPI’s Director of Clinical Supply Operations. Almac provided crucial clinical supply services for OAPI’s Abilify MaintenaTM (aripiprazole) clinical trial program, supporting the approval of the once-monthly injectable treatment for schizophrenia earlier in 2013.
“Pictured above is Almac’s Global VP of Operations, Celine Bradley, receiving an award of appreciation from Brent Kelly on behalf of Otsuka America Pharmaceutical, Inc. for Almac’s support in their Abilify MaintenaTM (aripiprazole) Product Study.”
This recognizes Almac’s commitment to quality, customer service, and operational excellence. Commenting on the award Celine Bradley, Almac’s Global VP of Operations said, “I am proud to receive this award from one of our valued customers, and I would like to congratulate OAPI on their successful registration of the Abilify Maintena product. Almac’s core values include our commitment to quality and customer focus, and it is very satisfying to have a client recognize when we have delivered on these. I would like to commend the Almac team for their dedication to successful and timely completion of this project. Awards like this highlight the importance of clinical trial supply in enabling our partners to make a real difference in patients’ lives.”
‘Partnering to Advance Human Health’
The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to over 600 companies globally within the pharmaceutical and biotech sectors. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS(R) technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown over 30 years and now employs in excess of 3,300 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with US operations based in Pennsylvania, North Carolina and California.